Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962

Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced

Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961

Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing

Trounce, I., Byrne, E., & Marzuki, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92143-0 · Cited by 730

Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's Disease

Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612

3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin

Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J. P., & Sabri, M. I. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 484

3-Nitropropionate, the toxic substance of Indigofera , is a suicide inactivator of succinate dehydrogenase

Alston, T. A., Mela, L., & Bright, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3767 · Cited by 382

Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry

Ferrante, R., Kowall, N., & Richardson, E. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03877.1991 · Cited by 306

Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage

Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 230

1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism

Storey, E., Hyman, B. T., Jenkins, B. G., Brouillet, E., Miller, J. M., Rosen, B. R., & Beal, M. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10080.x · Cited by 164

Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina.

Zeevalk, G. D., & Nicklas, W. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 164

3-Nitropropionic acid exacerbates N-methyl-d-aspartate toxicity in striatal culture by multiple mechanisms

Greene, J. G., Sheu, S. S., Gross, R. A., & Greenamyre, J. T. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00389-8 · Cited by 79

The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease

Jin, Y. N., & Johnson, G. V. W. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9286-7 · Cited by 80

Kaempferol protects MC3T3-E1 cells through antioxidant effect and regulation of mitochondrial function

Choi, E. M. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.031 · Cited by 77

Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotype

Krüger, R., Vieira-Saecker, A. M. M., Kuhn, W., Berg, D., M�ller, T., K�hnl, N., Fuchs, G., Storch, A., Hungs, M., Woitalla, D., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5 · Cited by 281

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

de Lago, E., Fernández‐Ruíz, J., Ortega‐Gutiérrez, S., Cabranes, A., Pryce, G., Baker, D., López-Rodríguez, M. L., & Ramos, J. A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.06.001 · Cited by 76

Chemical preconditioning: A cytoprotective strategy

Riepe, M. W., & Ludolph, A. C. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6111-8_39 · Cited by 75

Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity

Ahuja, M., Bishnoi, M., & Chopra, K. (2007) · Toxicology · doi:10.1016/j.tox.2007.11.003 · Cited by 74

Inhibitors of Mitochondrial Respiration, Iron (II), and Hydroxyl Radical Evoke Release and Extracellular Hydrolysis of Glutathione in Rat Striatum and Substantia Nigra

Han, J., Cheng, F., Yang, Z., & Dryhurst, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731683.x · Cited by 74

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats

Guyot, M., Palfi, S., Stutzmann, J. M., Mazière, M., Hantraye, P., & Brouillet, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00192-9 · Cited by 74

Glutamate Uptake Impairment and Neuronal Damage in Young and Aged Rats In Vivo

Massieu, L., & Tapia, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031151.x · Cited by 73

The Seed Extract of Cassia obtusifolia Offers Neuroprotection to Mouse Hippocampal Cultures

Drever, B. D., Anderson, W. G. L., Riedel, G., Kim, D. H., Ryu, J. H., Choi, D.-Y., & Platt, B. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08034fp · Cited by 74

Age-related toxicity to lactate, glutamate, and β-amyloid in cultured adult neurons

Brewer, G. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00091-8 · Cited by 73

Toward Understanding the Molecular Pathology of Huntington's Disease

Wellington, C. L., Brinkman, R. R., OʼKusky, J. R., & Hayden, M. R. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00897.x · Cited by 71

Acute Basal Ganglia Infarction in Propionic Acidemia

Haas, R., Marsden, D., Capistrano-Estrada, S. B., Hamilton, R. L., Grafe, M. R., Wong, W. H. M., & Nyhan, W. L. (1995) · Journal of Child Neurology · doi:10.1177/088307389501000104 · Cited by 70

Metabolic Compromise with Systemic 3-Nitropropionic Acid Produces Striatal Apoptosis in Sprague–Dawley Rats but Not in BALB/c ByJ Mice

Alexi, T., Hughes, P. E., Knüsel, B., & Tobin, A. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6842 · Cited by 70

The therapeutic role of creatine in Huntington's disease

Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.008 · Cited by 69

Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms

Mello, C. F., Begnini, J., Jiménez-Bernal, R. E., Rubin, M. A., de Bastiani, J., da Costa, E. J. M., & Wajner, M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00117-5 · Cited by 69

3-Nitropropionic Acid Increases the Intracellular Ca2+in Cultured Astrocytes by Reverse Operation of the Na+–Ca2+Exchanger

Deshpande, S. B., Fukuda, A., & Nishino, H. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6457 · Cited by 69

Mitochondrial toxins and neurodegenerative diseases

Ayala, A. (2006) · Frontiers in bioscience · doi:10.2741/2119 · Cited by 68

The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats

Mahdy, H. M., Tadros, M. G., Mohamed, M. R., Karim, A. M., & Khalifa, A. E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.07.012 · Cited by 68

Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy

Lee, W., Shen, Y.-C., & Chang, C. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00410-8 · Cited by 69

Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription

Tatton, W. G., Chalmers-Redman, R. M. E., Ju, W. Y. H., Wadia, J. S., & Tatton, N. A. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_25 · Cited by 68

Energy defects in Huntington's disease: Why “in vivo” evidence matters

Liot, G., Valette, J., Pépin, J., Flament, J., & Brouillet, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.065 · Cited by 65

Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease

Lee, W., & Chang, C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.002 · Cited by 67

Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

Essa, M. M., Moghadas, M., Ba-Omar, T., Qoronfleh, M. W., Guillemin, G. J., Manivasagam, T., Justin‐Thenmozhi, A., Ray, B., Bhat, A., Chidambaram, S. B., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9989-9 · Cited by 68

Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation

Teunissen, C. E., Steinbusch, H. W. M., Angevaren, M., Appels, M., Bruijn, C. D., Prickaerts, J., & de Vente, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00164-6 · Cited by 66

3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo

Sugino, T., Nozaki, K., Takagi, Y., & Hashimoto, N. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00875-1 · Cited by 65

Mitochondrial medicine

Luft, R., & Landau, B. R. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01218.x · Cited by 66

Comparative Analysis of Superoxide Dismutase Activity between Acute Pharmacological Models and a Transgenic Mouse Model of Huntington's Disease

Santamarı́a, A., Pérez‐Severiano, F., Rodrı́guez-Martı́nez, E., Maldonado, P. D., Pedraza‐Chaverrí, J., Rı́os, C., & Segovia, J. (2001) · Neurochemical Research · doi:10.1023/a:1010911417383 · Cited by 64

Huntington's Disease and Dentatorubral‐Pallidoluysian Atrophy: Proteins, Pathogenesis and Pathology

Ross, C. A., Bêcher, M. W., Colomer, V., Engelender, S., Wood, J. D., & Sham, A. H. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00898.x · Cited by 63

Towards an Understanding of Energy Impairment in Huntington’s Disease Brain

Dubinsky, J. M. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170264 · Cited by 63

Chemical preconditioning: A cytoprotective strategy

Riepe, M. W., & Ludolph, A. C. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006820927262 · Cited by 61

Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum

Nam, E.-J., Lee, S. M., Koh, S., Joo, W. S., Maeng, S., Im, H. I., & Kim, Y. S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.053 · Cited by 60

Systemic 3-nitropropionic acid: long-term effects on locomotor behavior

Koutouzis, T. K., Borlongan, C. V., Scorcia, T., Creese, I., Cahill, D. W., Freeman, T. B., & Sanberg, P. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90085-x · Cited by 60

Psychotropic and neurotropic activity

Vogel, H. G., & Vogel, W. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-03333-3_5 · Cited by 61

Oxidative Stress and Neuronal DNA Fragmentation Mediate Age-Dependent Vulnerability to the Mitochondrial Toxin, 3-Nitropropionic Acid, in the Mouse Striatum

Kim, G. W., & Chan, P. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0327 · Cited by 59

Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid

Fukuda, A., Deshpande, S. B., Shimano, Y., & Nishino, H. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00139-0 · Cited by 59

Improved Therapeutic Window for Treatment of Histotoxic Hypoxia with a Free Radical Spin Trap

Schulz, J. B., Matthews, R. T., Jenkins, B. G., Brar, P., & Beal, M. F. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.120 · Cited by 59

The 3‐NP Model of Striatal Neurodegeneration

Brouillet, E. (2014) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0948s67 · Cited by 58

MRS study of glutamate metabolism in cultured neurons/glia

Sonnewald, U., White, L. R., Ødegård, E., Westergaard, N., Bakken, I. J., Aasly, J. O., Unsgård, G., & Schousboe, A. (1996) · Neurochemical Research · doi:10.1007/bf02532408 · Cited by 58

3‐nitropropionic acid‐induced mitochondrial permeability transition: Comparative study of mitochondria from different tissues and brain regions

Mirandola, S. R., de Melo, D. R., Saito, Â., & Castilho, R. F. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22239 · Cited by 57

The Neuroprotective Role of Creatine

Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 56

Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum

Bowyer, J. F., Clausing, P., Schmued, L. C., Davies, D. L., BINIENDA, Z. K., Newport, G. D., Scallet, A. C., & Slikker, W. (1996) · Brain Research · doi:10.1016/0006-8993(95)01417-9 · Cited by 54

Protective effect of albiflorin against oxidative-stress-mediated toxicity in osteoblast-like MC3T3-E1 cells

Suh, K. S., Choi, E. M., Lee, Y., & Kim, Y. S. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.05.016 · Cited by 51

Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice

Urbańska, E. M., Błaszczak, P., Saran, T., Kleinrok, Z., & Turski, W. A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00648-7 · Cited by 51

Neuroprotective Effects of l‐Carnitine in Induced Mitochondrial Dysfunction

BINIENDA, Z. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07536.x · Cited by 51

Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid

Lima, T. T. F., Begnini, J., de Bastiani, J., Fialho, D. B., Jurach, A., Ribeiro, M. C. P., Wajner, M., & Mello, C. F. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00563-0 · Cited by 50

Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease

Chakraborty, J., Nthenge-Ngumbau, D. N., Rajamma, U., & Mohanakumar, K. P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.048 · Cited by 49

In vivo vulnerability of dopamine neurons to inhibition of energy metabolism

Zeevalk, G. D., Manzino, L., Hoppe, J., & Sonsalla, P. K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00892-8 · Cited by 49

Neuronal Mitophagy: Friend or Foe?

Doxaki, C., & Palikaras, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611938 · Cited by 48

Chapter 1 Mechanisms of Nerve Cell Death: Apoptosis or Necrosis After Cerebral Ischaemia

Chalmers-Redman, R. M. E., Fraser, A., Ju, W. Y. H., Wadia, J. S., Tatton, N. A., & Tatton, W. G. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60713-8 · Cited by 48

Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation

Borlongan, C. V., Nishino, H., & Sanberg, P. R. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00045-x · Cited by 48

Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease

Gupta, S., & Sharma, B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.032 · Cited by 47

The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease

Blum, D. L., Chern, Y., Domenici, M. R., Buée, L., Lin, C., Rea, W. P., Ferré, S., & Popoli, P. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0006 · Cited by 48

Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study

Rodríguez, A. I., Willing, A. E., Saporta, S., Cameron, D. F., & Sanberg, P. R. (2003) · Neurotoxicity Research · doi:10.1007/bf03033174 · Cited by 45

Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients

Seo, H., Kim, W., & Ole Isacson, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn211 · Cited by 43

3-nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons

Weller, M., & Paul, S. M. (1993) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(93)90048-u · Cited by 42

Age-Dependent Differences in Survival of Striatal Somatostatin–NPY–NADPH–Diaphorase-Containing Interneurons versus Striatal Projection Neurons after Intrastriatal Injection of Quinolinic Acid in Rats

Figueredo-Cardenas, G., Chen, Q., & Reiner, A. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6549 · Cited by 40

3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro

Olsen, C. M., Rustad, A., Fonnum, F., Paulsen, R. E., & Hassel, B. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02115-0 · Cited by 39

HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo

Ehrnhoefer, D. E., Southwell, A. L., Sivasubramanian, M., Qiu, X., Villanueva, E. B., Xie, Y., Waltl, S., Anderson, L. M., Fazeli, A., Casal, L. L., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx394 · Cited by 38

Safety assessment of β-nitropropionic acid: a monograph in support of an acceptable daily intake in humans

Burdock, G. A., Carabin, I. G., & Soni, M. G. (2001) · Food Chemistry · doi:10.1016/s0308-8146(01)00194-7 · Cited by 38

In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid

Kraft, J. C., Osterhaus, G. L., Ortiz, A. N., Garris, P. A., & Johnson, M. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.083 · Cited by 38

3-Acetylpyridine Produces Age-Dependent Excitotoxic Lesions in Rat Striatum

Schulz, J. B., Henshaw, D. R., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.134 · Cited by 37

Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production

Villarán, R. F., Tomás‐Camardiel, M., de Pablos, R. M., SANTIAGO, M., Herrera, A. J., NAVARRO, A., Machado, A. M., & CANO, J. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.11.001 · Cited by 36

Tert-buthylhydroquinone pre-conditioning exerts dual effects in old female rats exposed to 3-nitropropionic acid

Silva‐Palacios, A., Colín-González, A. L., López-Cervantes, S. P., Zazueta, C., Luna‐López, A., Santamarı́a, A., & Königsberg, M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.029 · Cited by 36

Transcriptional Dysregulation in Huntington’s Disease: The Role in Pathogenesis and Potency for Pharmacological Targeting

Pogoda-Wesołowska, A., Chmielewska, N., Maciejak, P., & Szyndler, J. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200705225821 · Cited by 38

Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats

Kadir, A., Singh, J., Rahi, V., & Kumar, P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03677-y · Cited by 36

Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging

Chyi, T., & Chang, C. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00076-7 · Cited by 36

Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid

Araujo, D. M., & Hilt, D. C. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00266-2 · Cited by 35

Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration

BINIENDA, Z. K., & Kim, C. S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00514-4 · Cited by 35

Huntington's disease: animal models and transplantation repair

Dunnett, S. B., & Svendsen, C. N. (1993) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(93)90155-r · Cited by 35

Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease

Lastres‐Becker, I., Gómez‐Ruíz, M., de Miguel, R., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Neurotoxicity Research · doi:10.1080/10298420290030514 · Cited by 34

Early Reactive A1 Astrocytes Induction by the Neurotoxin 3-Nitropropionic Acid in Rat Brain

López‐Sánchez, C., García‐Martínez, V., Poejo, J., García‐López, V., Salazar, J., & Gutiérrez‐Merino, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103609 · Cited by 35

3-Nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils

Kuroiwa, T., Yamada, I., Endo, S., Hakamata, Y., & Ito, U. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00937-x · Cited by 34

Trinucleotide repeats in neurologic diseases: An hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I

Cha, J.-H. J., & Dure, L. S. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90012-4 · Cited by 34

Bilateral Fetal Striatal Grafts in the 3-Nitropropionic Acid-Induced Hypoactive Model of Huntington's Disease

Borlongan, C. V., Koutouzis, T. K., Poulos, S. G., Saporta, S., & Sanberg, P. R. (1998) · Cell Transplantation · doi:10.1016/s0963-6897(97)00170-x · Cited by 34

Dearth of glutamate transporters contributes to striatal excitotoxicity

Brustovetsky, T., Purl, K. J., YOUNG, A., SHIMIZU, K., & Dubinsky, J. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.021 · Cited by 33

3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum

Fu, Y. (1995) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)00076-p · Cited by 33

Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization

Tsai, M. J., Goh, C. C., Wan, Y., & Chang, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00015-8 · Cited by 33

Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies

Wang, L., & Qin, Z. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00410.x · Cited by 32

Consistent striatal damage in rats induced by 3-nitropropionic acid and cultures of arthrinium fungus

Fu, Y., He, F., Zhang, S.-L., & Jiao, X. (1995) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)00078-r · Cited by 32

Luteolin protects osteoblastic MC3T3-E1 cells from antimycin A-induced cytotoxicity through the improved mitochondrial function and activation of PI3K/Akt/CREB

Choi, E. M. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.07.004 · Cited by 31

Effect of 3-Nitropropionic Acid on Kynurenine Aminotransferase in the Rat Brain

Csillik, A. E. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7973 · Cited by 29

Neuroprotective effect of l-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats

BINIENDA, Z. K., Virmani, A., Przybyla‐Zawislak, B., & Schmued, L. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.031 · Cited by 29

l ‐Carnitine and Neuroprotection in the Animal Model of Mitochondrial Dysfunction

BINIENDA, Z. K., Przybyla‐Zawislak, B., Virmani, A., & Schmued, L. C. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00023.x · Cited by 29

Pharmacological evidence that α-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats

Coitinho, A. S., Mello, C. F., Lima, T. T. F., de Bastiani, J., Fighera, M. R., & Wajner, M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03321-7 · Cited by 29

Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes

Bougria, M., Vitórica, J., Cano, J., & Machado, A. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90083-7 · Cited by 29

Mitochondrial toxin inhibition of [3H]dopamine uptake into rat striatal synaptosomes

Maragos, W. F., Zhu, J., Chesnut, M. D., & Dwoskin, L. P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00910-3 · Cited by 28

The role of mycotoxins in neurodegenerative diseases: current state of the art and future perspectives of research

Nguyen, V. T. T., König, S., Eggert, S., Endres, K., & Kins, S. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0214 · Cited by 28

Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine

Elinos, D., Robledo-Arratia, Y., de la Cruz, V. P., Maldonado, P. D., Galván‐Arzate, S., Pedraza‐Chaverrí, J., & Santamarı́a, A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0299-5 · Cited by 27

White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat

McCracken, E., Dewar, D., & Hunter, A. J. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03266-2 · Cited by 27

Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism

Geddes, J. W., Pang, Z., & Wiley, D. H. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815206 · Cited by 27

Differential Involvement of Cell Cycle Reactivation between Striatal and Cortical Neurons in Cell Death Induced by 3-Nitropropionic Acid

Akashiba, H., Ikegaya, Y., Nishiyama, N., & Matsuki, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707730200 · Cited by 26

Early-onset tolerance in rat global cerebral ischemia induced by a mitochondrial inhibitor

Nakase, H., Heimann, A., Uranishi, R., Riepe, M. W., & Kempski, O. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01345-8 · Cited by 26

Treatment with Dehydroepiandrosterone Prevents Oxidative Stress Induced by 3-Nitropropionic Acid in Synaptosomes

Túnez, I., Muñoz, M. C., & Montilla, P. (2005) · Pharmacology · doi:10.1159/000084169 · Cited by 26

Estrogen blocks 3-nitropropionic acid-induced [Ca2+]i increase and cell damage in cultured rat cerebral endothelial cells

Mogami, M., Hida, H., Hayashi, Y., Kohri, K., Kodama, Y., Jung, C., & Nishino, H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03488-1 · Cited by 26

Immunocytochemical Characterization of the Mitochondrially Encoded ND1 Subunit of Complex I (NADH : Ubiquinone Oxidoreductase) in Rat Brain

Pettus, E. H., Betarbet, R. S., Cottrell, B. A., Wallace, D. C., Madyastha, V., & Greenamyre, J. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750383.x · Cited by 26

Pharmacological benefit of I1-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease

Gupta, S., & Sharma, B. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.02.007 · Cited by 25

High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry

Son, S., Bowie, L. E., Maiuri, T., Hung, C. L.-K., Desmond, C. R., Xia, J., & Truant, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001440 · Cited by 24

Neuroprotective Effects of Free Radical Scavengers and Energy Repletion in Animal Models of Neurodegenerative Disease

Schulz, J. B., & Beal, M. F. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb16565.x · Cited by 24

Age dependence of striatal neuronal death caused by mitochondrial dysfunction

Bossi, S. R., Simpson, J. R., & Isacson, O. (1993) · Neuroreport · doi:10.1097/00001756-199301000-00019 · Cited by 80

3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

Brouillet, E., Jacquard, C., Bizat, N., & Blum, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03515.x · Cited by 371

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026

Mice Transgenic for the Huntington's Disease Mutation Are Resistant to Chronic 3‐Nitropropionic Acid‐Induced Striatal Toxicity

Hickey, M. A., & Morton, A. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752163.x · Cited by 53

3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum

Borlongan, C. V., & Sanberg, P. R. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_5